The major components of HSPC, or hydrogenated soy phosphatidylcholine, are primarily phospholipids, with phosphatidylcholine being the predominant phospholipid species [1]. Hydrogenation modifies these phospholipids by saturating their fatty acid chains [2].
What are the different types of phospholipids in HSPC?
While phosphatidylcholine is the main component, HSPC mixtures can also contain other phospholipids, such as phosphatidylethanolamine and phosphatidylinositol, which are also derived from soy lecithin [3]. The hydrogenation process specifically targets the double bonds in the fatty acid tails of these phospholipids.
How does hydrogenation affect the properties of soy phosphatidylcholine?
Hydrogenation saturates the unsaturated fatty acid chains within phosphatidylcholine. This process removes double bonds, transforming polyunsaturated and monounsaturated fatty acids into saturated fatty acids. This saturation increases the stability of the phospholipids, making them less prone to oxidation and improving their shelf life [2].
Where is HSPC used?
HSPC is commonly used in pharmaceutical formulations as an excipient, particularly in liposomes. Its stability and biocompatibility make it a suitable component for drug delivery systems, helping to encapsulate and deliver active pharmaceutical ingredients [1]. It is also found in some food products as an emulsifier [3].
What is the difference between soy lecithin and hydrogenated soy phosphatidylcholine?
Soy lecithin is a raw extract from soybeans that contains a mixture of phospholipids, including phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol, as well as triglycerides and other lipids. Hydrogenated soy phosphatidylcholine (HSPC) is derived from soy lecithin through a process that saturates the fatty acid chains of the phospholipids, primarily phosphatidylcholine, enhancing stability [2, 3].
How is HSPC manufactured?
HSPC is produced by hydrogenating crude soy lecithin. This involves treating the lecithin with hydrogen gas in the presence of a catalyst. The process saturates the double bonds in the fatty acid chains of the phospholipids, altering their physical and chemical properties [2].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/